Recent clinical trials in people with type 2 diabetes have demonstrated beneficial actions on
heart and kidney outcomes following treatment with GLP-1RAs. In part, these actions are …

Glucose homeostasis is mainly under the control of the pancreatic islet hormones insulin
and glucagon, which, respectively, stimulate glucose uptake and utilization by liver, fat, and …

Abstract Glucagon-like peptide 1 (GLP-1), a gastrointestinal peptide and central mediator of
glucose metabolism, is secreted by L cells in the intestine in response to food intake …

In recent years, we have witnessed the many beneficial effects of glucagon‐like peptide
(GLP)‐1 receptor agonists, including the reduction in cardiovascular risk in patients with type …

Background Biological aging is an important factor leading to the development of
pathologies associated with metabolic dysregulation, including type 2 diabetes, cancer …

Ipomoea batatas L.(IBL) has gained significant popularity as a complementary therapy or
herbal medicine in the treatment of anti-diabetes. This review seeks to explore the …

Background A growing body of evidence suggests that particulate matter (PM10) enters the
gastrointestinal (GI) tract directly, causing the GI epithelial cells to function less efficiently …

Abstract Dipeptidyl peptidase IV (DPP-IV) is an enzyme responsible for the degradation of
the incretin hormone glucagon-like peptide-1 (GLP-1). DPP-IV plays a significant role in …

The study investigates the effects of wheat biscuits supplemented with plant flours
originating from legumes/seeds enriched either in L-arginine (L-arg) or branched-chain …

Introduction Diet stands as a pivotal modifiable risk factor influencing weight gain and the
onset of type-2 diabetes (T2D). This study delves into the variation in glucose and regulatory …